Locked contact intelligence
Contact Details & Ownership
Reveal verified contact points, shareholder visibility, and group structure signals beyond the public summary.
Contact DetailsShareholdersGroup StructureCorporate Network Graph
Back to search
Company profile
ASTRAZENECA PLC
active • plc • 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom
Company no.02723534Officers69Documents20
Key company facts
Core operating details surfaced from the public profile endpoint.
- Company Number
- 02723534
- Company Status
- active
- Type
- plc
- Date Of Creation
- 1992-06-17
- Registered Office
- 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom
- Sic Codes
- manufacture of basic pharmaceutical products, manufacture of pharmaceutical preparations, wholesale of pharmaceutical goods, research and experimental development on biotechnology
Financials
A cleaner view of the latest filing, balance sheet movement, and multi-year trend.
Total assets
£114,074
Equity
£48,719
Total liabilities
£65,355
Cash in bank
£5,711
Year-on-year movement
Quick comparison from the latest filed period.
2025-12-31
Equity
+£7.85k
+19.20%Cash in bank
+£223.00
+4.06%Total assets
+£10.04k
+9.65%Total liabilities
-£2.19k
-3.47%Financial trend
Multi-year view of the main balance sheet lines.
Net Assets
Total Assets
Total Liabilities
£114,074£24,360-£65,355
2022202320242025
Latest snapshot
Financial year2025
Statement date2025-12-31
Trade debtors—
Trade creditors—
Fixed assets—
Current assets—
| Year | Net Assets | Total Assets | Total Liabilities |
|---|---|---|---|
| 2022 | £37,058 | £96,483 | -£59,425 |
| 2023 | — | — | £0 |
| 2024 | £40,871 | £104,035 | -£63,164 |
| 2025 | £48,719 | £114,074 | -£65,355 |
Available In The Full Platform
Unlock deeper company intelligence
More company intelligence is available through your account, including premium data, deeper records, and advanced insight.
Locked compliance screening
Risk & Compliance
Access enhanced due diligence signals for KYC, sanctions, adverse media, phoenix risk, and register visibility.
KYC+Adverse Media ScreeningPhoenix Detection SummaryFCA Register
Locked financial insight
Financial Intelligence
Unlock premium financial analysis including credit insight, risk scoring, and AI-assisted valuation signals.
AI Financial Risk InsightsAI Company ValuationCredit ScoreCharges
Locked filing intelligence
Assets, Filings & Registers
Go beyond the headline profile with deeper asset, filing, register, and notice-level intelligence.
PropertyTrademarkGazette NoticesCharges
Latest activity
Recent company and officer updates, reshaped from the watchlist activity source for public profile use.
| Update | Date | Recency |
|---|---|---|
| HAAS, Rene Anthony Andrada Resigned | 30 Apr 2026 | 17 Days |
| Accounts Submitted | 25 Apr 2026 | 21 Days |
| RAHMAN, Sabera Nazneen Resigned | 9 Apr 2026 | 1 Month |
| Confirmation Statement Submitted | 28 May 2025 | 11 Months |
| BOWDEN, Matthew Shaun Appointed | 1 May 2025 | 1 Year |
| KEMP, Adrian Charles Noel Resigned | 1 May 2025 | 1 Year |
| Accounts Submitted | 23 Apr 2025 | 1 Year |
| ELDRACHER, Deborah Disanzo Resigned | 11 Apr 2025 | 1 Year |
| RUMMELT, Andreas Resigned | 11 Apr 2025 | 1 Year |
| COSTELLO, Karen Elizabeth Knudsen Appointed | 11 Apr 2025 | 1 Year |
| CONIX, Birgit Appointed | 1 Feb 2025 | 1 Year |
| HAAS, Rene Anthony Andrada Appointed | 1 Jan 2025 | 1 Year |
Documents
Public filing documents and direct PDF links where available.
| Description | Date | Document |
|---|---|---|
| termination-director-company-with-name-termination-date | 2026-05-01 | Open PDF |
| resolution | 2026-04-30 | Open PDF |
| auditors-resignation-company | 2026-04-27 | Open PDF |
| accounts-with-accounts-type-group | 2026-04-25 | Open PDF |
| termination-director-company-with-name-termination-date | 2026-04-13 | Open PDF |
| capital-allotment-shares | 2026-04-09 | Open PDF |
| capital-allotment-shares | 2026-03-12 | Open PDF |
| capital-allotment-shares | 2026-03-02 | Open PDF |
| capital-allotment-shares | 2025-12-28 | Open PDF |
| legacy | 2025-12-19 | Open PDF |
| capital-allotment-shares | 2025-12-05 | Open PDF |
| change-sail-address-company-with-old-address-new-address | 2025-11-19 | Open PDF |